CELLUPRO LTD
Overview
CELLUPRO LTD is an active pharmaceutical ingredient (API) supplier with 7 active FDA Type II Drug Master Files, covering CELLIMAX CHO E MEDIUM; CELLIMAX CHO FGA MEDIUM; CELLMAX CHO FGB MEDIUM; F109 MEDIUM; MAXP CHO F100 MEDIUM; SFM001 MEDIUM.
API / Drug Master Files
CELLUPRO LTD holds 8 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- MAXP CHO 100 MEDIUMActive2026-06-18
- CELLIMAX CHO FGA MEDIUMActive2025-06-17
- CELLIMAX CHO E MEDIUMActive2025-05-22
- CELLMAX CHO FGB MEDIUMActive2025-05-22
- F109 MEDIUMActive2024-12-16
- SFM001 MEDIUMActive2024-10-11
- MAXP CHO F100 MEDIUMActive2023-06-26
- SFM002 MEDIUMActive2023-06-26
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to CELLUPRO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this CELLUPRO LTD? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.